← Open Payments lookup

TAYLOR SHEPARD: Open Payments

NPI 1689332496 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$237 in 12 payments from 6 companies in 2025. Trend: 2023 $137 · 2024 $377 · 2025 $237

Food & beverage: $237
CompanyPaymentsAmount
GlaxoSmithKline, LLC.4$79
Bioventus LLC2$44
Ferring Pharmaceuticals Inc.2$44
DePuy Synthes Sales Inc.2$31
Pacira Pharmaceuticals Incorporated1$20
Smith+Nephew, Inc.1$20

Products named: NUCALA, DUROLANE, EUFLEXXA, Iovera, Pico 14, ORTHOVISC, MONOVISC.

Industry payments across TX — which companies pay providers there.